China Medical System Holdings Limited (FRA:2M7C)

Germany flag Germany · Delayed Price · Currency is EUR
1.430
-0.040 (-2.72%)
At close: Oct 17, 2025
-2.72%
Market Cap3.52B
Revenue (ttm)934.24M
Net Income (ttm)196.19M
Shares Outn/a
EPS (ttm)0.08
PE Ratio17.93
Forward PE15.86
Dividend0.03 (2.32%)
Ex-Dividend DateAug 29, 2025
Volume1,390
Average Volume973
Open1.430
Previous Close1.470
Day's Range1.410 - 1.430
52-Week Range0.805 - 1.650
Betan/a
RSI40.11
Earnings DateNov 19, 2025

About FRA:2M7C

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China. The company offers cardio-cerebrovascular products include VELPHORO, a sucroferric oxyhydroxide chewable tablets and diazepam nasal spray for seizure clusters; XinHuoSu, a recombinant human brain natriuretic peptide for acute heart failure; Plendil, a felodipine sustained release tablets for hypertension; and Deanxit, a flupentixol and melitracen tablets for mild-to-moderate ... [Read more]

Industry Pharmaceutical Preparations
Founded 1995
Employees 6,141
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 2M7C
Full Company Profile

Financial Performance

In 2024, FRA:2M7C's revenue was 7.47 billion, a decrease of -6.79% compared to the previous year's 8.01 billion. Earnings were 1.62 billion, a decrease of -32.54%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.